https://www.selleckchem.com/products/VX-770.html
In the present study, we retrospectively analysed the results of HSCT in 47 consecutive patients with MDS diagnosed at our department between 2002 and 2019, with a focus on possible predictive factors influencing overall survival (OS), the development of relapse, infections, and the occurrence of graft versus host disease (GvHD). In a univariate analysis, the pre-transplantation value of blasts in the marrow 213 U/l) was associated with shorter OS (p = 0.04). Immune checkpoint inhibitor therapy is rapidly becoming front line adjuvant or
Like
Comment
Share
